Mesangial cell turnover in normal glomeruli is a slow and orderly process. The presence of mitogenic stimuli such as inflammation, elevated levels of certain hormones and growth factors increase mesangial cell turnover. The source(s) of proliferating mesangial cells in maintenance in the normal glomerular structure or in disease has not been determined. Since the majority of cells in adult tissues, including mesangial cells, are thought to be terminally differentiated and have lost their capacity to replicate, we postulate that proliferating mesangial cells be composed of progenitor or stem cells. We hypothesize that mesangial cell progenitors reside both in the bone marrow and in the glomerulus. We further hypothesize that mesangial progenitor cells in the bone marrow are a major source of cells involved in mesangial cell proliferation in the glomerular injury response. Our preliminary data suggests that cultured mouse mesangial cells exhibit properties of progenitor cells, including an extended replicative life span in vitro and the ability to home to glomeruli in vivo. We propose to determine if the lack of replicative senescence in these cells is due to the acquisition of genetic changes that allow them to escape cell cycle arrest. In addition, we propose to confirm the homing capacity and specificity of these cells. Our data suggest that bone marrow derived mesangial cell progenitors play an important role in mesangial cell turnover. We found that lethal irradiation eliminates both bone marrow and glomerular local mesangial cell progenitors. We will use this method to dissect the role of bone marrow and glomerular local progenitors in reconstituting the mesangial cells after snake venom induced injury. Finally, we will examine the trafficking of mesangial cell progenitors between bone marrow and glomeruli. ? ? In summary, this proposal will lead to the identification of the source(s) of normal glomerular mesangial cell progenitors, the role of bone marrow derived mesangial cell progenitors in reconstitution of the mesangium after injury, and the trafficking of mesangial cell progenitors between the bone marrow and glomeruli. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Exploratory/Developmental Grants (R21)
Project #
7R21DK064118-03
Application #
6992290
Study Section
General Medicine B Study Section (GMB)
Program Officer
Wilder, Elizabeth L
Project Start
2003-08-05
Project End
2006-06-30
Budget Start
2004-09-01
Budget End
2006-06-30
Support Year
3
Fiscal Year
2004
Total Cost
$146,962
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Park, C W; Zhang, Y; Zhang, X et al. (2006) PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice. Kidney Int 69:1511-7
Feng, Zheng; Plati, Anna Rita; Cheng, Qing-li et al. (2005) Glomerular aging in females is a multi-stage reversible process mediated by phenotypic changes in progenitors. Am J Pathol 167:355-63
Zheng, Feng; Cornacchia, Flavia; Schulman, Ivonne et al. (2004) Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors. Diabetes 53:2420-7
Zheng, Feng; Cheng, Qing-Li; Plati, Anna-Rita et al. (2004) The glomerulosclerosis of aging in females: contribution of the proinflammatory mesangial cell phenotype to macrophage infiltration. Am J Pathol 165:1789-98